SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-02-000121
Filing Date
2002-02-04
Accepted
2002-02-04 00:00:00
Documents
1
Group Members
MERLIN BIOMED GROUP, L.L.C.MERLIN BIOMED II, L.P.MERLIN BIOMED III, L.P.MERLIN BIOMED INVESTMENT ADVISORS, L.L.C.MERLIN BIOMED, L.P.STUART T. WEISBROD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G sch13ga_012802.txt SC 13G/A 16953
  Complete submission text file 0000947871-02-000121.txt   19050
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46256 | Film No.: 02525837
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 237 PARK AVE STE 801 NEW YORK NY 10017
Business Address 237 PARK AVE STE 801 NEW YORK NY 10017 2128087425
MERLIN BIOMED GROUP LLC (Filed by) CIK: 0001106843 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231